Related Experiment Video
Updated: Jul 7, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Primer binding site-dependent restriction of murine leukemia virus requires HP1 binding by TRIM28
Daniel Wolf1, Florence Cammas, Régine Losson
1Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, HHSC 1310, 701 West 168th Street, New York, NY 10032, USA.
Abstract:
TRIM28 is a transcriptional corepressor which is required for primer binding site (PBS)-dependent restriction of murine leukemia virus (MLV) replication in embryonic stem and embryonic carcinoma (EC) cells. PBS-dependent restriction of MLV leads to transcriptional silencing of the integrated provirus and has been shown to correlate with TRIM28-mediated recruitment of HP1 to the silenced loci. Here we show, using a cell line with a point mutation in the HP1 binding domain of TRIM28, that interaction with HP1 is absolutely required for the PBS-dependent restriction of MLV in the F9 EC cell line.
Insights
Tripartite motif-containing protein 28 (TRIM28) is essential for restricting murine leukemia virus (MLV) replication in specific cells. Its interaction with Heterochromatin protein 1 (HP1) is crucial for this antiviral defense mechanism.
Area of Science:
- Molecular Biology
- Virology
- Epigenetics
Background:
- Tripartite motif-containing protein 28 (TRIM28) acts as a transcriptional corepressor.
- TRIM28 mediates the restriction of murine leukemia virus (MLV) replication in embryonic stem and carcinoma cells via primer binding site (PBS) dependence.
- This restriction involves transcriptional silencing of the provirus and recruitment of Heterochromatin protein 1 (HP1) to silenced genetic loci.
Purpose of the Study:
- To investigate the role of the TRIM28-HP1 interaction in PBS-dependent MLV restriction.
- To determine if HP1 recruitment by TRIM28 is essential for MLV transcriptional silencing.
Main Methods:
- Utilized a cell line engineered with a point mutation in the HP1 binding domain of TRIM28.
- Assessed MLV replication and proviral silencing in the mutant cell line.
- Analyzed TRIM28-HP1 interaction dynamics.
Main Results:
- The point mutation in the TRIM28 HP1 binding domain abolished the PBS-dependent restriction of MLV.
- TRIM28-mediated recruitment of HP1 to silenced loci was demonstrated to be essential for MLV restriction.
- The interaction between TRIM28 and HP1 is critical for the antiviral activity in F9 EC cells.
Conclusions:
- The interaction between TRIM28 and HP1 is indispensable for the primer binding site-dependent restriction of MLV.
- TRIM28's ability to recruit HP1 is a key mechanism for achieving MLV transcriptional silencing and antiviral defense in embryonic carcinoma cells.
Related Concept Videos
Leaky Scanning
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

